Latest Compliance News

ASF Group finished FY2026 with A$5.19 million in cash, no outstanding borrowings and a materially stronger net asset position after selling several investments. But the A$4.09 million profit was still largely disposal-led, while operating cash flow remained negative and recurring revenue declined.

Immutep’s pivotal TACTI-004 lung cancer trial dominates a difficult FY26, with the failure widening the loss to A$79.3 million and triggering an impairment, cost cuts and a root cause review. The biotech retains A$68.9 million in cash, cash equivalents and term deposits, while its remaining investment case rests on IMP761 and selected efti studies.

The Star Entertainment returned to positive quarterly EBITDA in Q1 FY27, with Sydney and Gold Coast revenue recording year-on-year growth for the first time since quarterly reporting began. The improvement comes alongside negative reported operating cash flow, continuing casino licence restrictions and unresolved going-concern uncertainties.

Eve Health Group (ASX:EVE) says it knows of no undisclosed information that would explain a sharp fall and surge in trading volume. The company suggested selling by a formerly associated shareholder may have contributed, without identifying the seller or quantifying the disposal.

Bougainville Copper has asked the ASX to reinstate quotation trading after lodging its delayed half-year report, but the exchange has not yet approved a resumption. The company has acknowledged repeated reporting failures and introduced tighter internal controls.

Elementos has secured approval for the 8.1km access corridor at its Oropesa tin project in Spain and made its Robledollano smelter option unconditional. The company ended September with A$38.6 million in cash, but still needs primary permits, financing and offtake agreements before a final investment decision.

Sarytogan Graphite has completed a 50,000-tonne-a-year upstream graphite DFS and extended copper porphyry exploration in Kazakhstan, but held only A$1.015 million in cash at quarter end. The company estimates that balance represents 0.88 quarters of funding at its recent spending rate, leaving project financing and potential capital raising firmly in focus.

Sarytogan Graphite’s trading suspension is due to be lifted after the company releases details of a Supreme Court of Western Australia application over an inadvertently unlodged prospectus for SGAO Options. The filing provides no detail on potential orders, penalties or investor remedies.

Kinatico has started FY27 with SaaS revenue up 17.8% and cash 21.8% higher, while its expanded compliance platform moves into production with Civeo and new customers. The company is also pursuing an exclusive childcare partnership with OWNA, but the commercial terms remain undisclosed.

Reedy Lagoon has issued 1.44 billion shares at $0.00125 each, completing the shareholder-approved placement and injecting approximately $1.8 million before costs. The Section 708A notice clears the shares for trading without further disclosure, but the filing leaves the enlarged capital structure and use of funds unstated.

Beamtree Holdings has paired 10% recurring revenue growth with a $13.1 million non-cash impairment and a year-end debt covenant breach. The ASX-listed healthcare software company is betting that a tighter product portfolio, new leadership and FY27 execution can stabilise the balance sheet.

Element 25 has moved its Butcherbird expansion further into delivery, combining early site works with a binding manganese offtake and a potential AU$50 million project finance package. The project still needs financial close, approvals and major construction contracts before the plan becomes an operating mine.